Holdings (Monthly)
Guide ↗
Direxion Daily Pharmaceutical & Medical Bull 3X Shares
· Direxion Shares ETF Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | GOLDMAN FINANCIAL | N/A | Apr 2024 | 4,234,149 | $4.2M | 23.61% | STIV |
| 2 | GOLDMAN SACHS LIQ ES FD A | N/A | Apr 2024 | 870,000 | $870K | 4.85% | STIV |
| 3 | DREYFUS GOVERNMENT CASH MANAGE | N/A | Apr 2024 | 799,135 | $799K | 4.46% | STIV |
| 4 | Definium Therapeutics Inc. | DFTX | Jan 2026 | 20,697 | $349K | 1.95% | EC |
| 5 | Liquidia Corporation | LQDA | Apr 2024 | 7,842 | $332K | 1.85% | EC |
| 6 | MBX Biosciences, Inc. | MBX | Jan 2026 | 8,892 | $328K | 1.83% | EC |
| 7 | Axsome Therapeutics Inc. | AXSM | Apr 2024 | 1,717 | $316K | 1.76% | EC |
| 8 | Organon & Co | OGN | Apr 2024 | 35,686 | $305K | 1.70% | EC |
| 9 | Edgewise Therapeutics Inc. | EWTX | Jul 2024 | 10,795 | $304K | 1.69% | EC |
| 10 | Elanco Animal Health Inc | ELAN | Apr 2024 | 12,030 | $290K | 1.62% | EC |
| 11 | Merck & Co., Inc | MRK | Apr 2024 | 2,624 | $289K | 1.61% | EC |
| 12 | Viatris Inc | VTRS | Apr 2024 | 22,089 | $289K | 1.61% | EC |
| 13 | Amneal Pharmaceuticals Inc | AMRX | Apr 2024 | 20,985 | $287K | 1.60% | EC |
| 14 | Johnson & Johnson | JNJ | Apr 2024 | 1,240 | $282K | 1.57% | EC |
| 15 | Royalty Pharma PLC | RPRX | Apr 2024 | 6,700 | $279K | 1.56% | EC |
| 16 | Amylyx Pharmaceuticals Inc | AMLX UW | Jan 2026 | 19,369 | $277K | 1.54% | EC |
| 17 | Bristol-Myers Squibb Company | BMY | Apr 2024 | 5,005 | $276K | 1.54% | EC |
| 18 | Xeris Biopharma Holdings Inc | XERS UW | Apr 2024 | 36,921 | $272K | 1.52% | EC |
| 19 | Zoetis Inc. | ZTS | Apr 2024 | 2,171 | $271K | 1.51% | EC |
| 20 | Perrigo Company PLC | PRGO | Apr 2024 | 18,954 | $269K | 1.50% | EC |
| 21 | Prestige Consumer Healthcare Inc | PBH | Apr 2024 | 4,175 | $269K | 1.50% | EC |
| 22 | Ligand Pharmaceuticals Incorporated | LGND | Apr 2024 | 1,392 | $267K | 1.49% | EC |
| 23 | Supernus Pharmaceuticals, Inc | SUPN | Apr 2024 | 5,552 | $267K | 1.49% | EC |
| 24 | Eli Lilly & Co. | LLY | Apr 2024 | 257 | $267K | 1.49% | EC |
| 25 | Crinetics Pharmaceuticals Inc. | CRNX | Jan 2026 | 5,332 | $266K | 1.48% | EC |
| 26 | Pfizer Inc. | PFE | Apr 2024 | 9,939 | $263K | 1.47% | EC |
| 27 | Arvinas Inc | ARVN | Apr 2024 | 19,344 | $259K | 1.44% | EC |
| 28 | Avadel Pharmaceuticals PLC | AVDL | Jan 2026 | 11,928 | $257K | 1.43% | EC |
| 29 | ANI Pharmaceuticals Inc. | ANIP | Apr 2024 | 3,126 | $256K | 1.43% | EC |
| 30 | Indivior Pharmaceuticals Inc. | 2624324 | Jan 2026 | 7,230 | $256K | 1.43% | EC |
| 31 | Jazz Pharmaceuticals PLC | JAZZ | Apr 2024 | 1,554 | $256K | 1.43% | EC |
| 32 | Enliven Therapeutics Inc | ELVN | Jul 2024 | 9,664 | $256K | 1.43% | EC |
| 33 | Maze Therapeutics Inc | MAZE | Jan 2026 | 5,747 | $250K | 1.40% | EC |
| 34 | Innoviva Inc | INVA | Apr 2024 | 12,428 | $249K | 1.39% | EC |
| 35 | Collegium Pharmaceutical Inc. | COLL | Apr 2024 | 5,244 | $241K | 1.34% | EC |
| 36 | Phibro Animal Health Corporation | PAHC | Jan 2026 | 5,959 | $239K | 1.33% | EC |
| 37 | Harmony Biosciences Holdings Inc | HRMY | Apr 2024 | 6,525 | $238K | 1.33% | EC |
| 38 | Rapport Therapeutics Inc | RAPP | Jan 2026 | 8,550 | $228K | 1.27% | EC |
| 39 | Esperion Therapeutics Inc | ESPR | Jan 2026 | 66,906 | $227K | 1.26% | EC |
| 40 | Amphastar Pharmaceuticals Inc | AMPH | Apr 2024 | 8,420 | $223K | 1.24% | EC |
| 41 | Pacira Biosciences Inc | PCRX | Apr 2024 | 10,177 | $209K | 1.17% | EC |
| 42 | Harrow Inc | HROW | Jul 2024 | 5,104 | $209K | 1.17% | EC |
| 43 | Ventyx Biosciences Inc. | VTYX | Jan 2026 | 14,947 | $209K | 1.16% | EC |
| 44 | Phathom Pharmaceuticals Inc | PHAT | Jan 2026 | 15,183 | $208K | 1.16% | EC |
| 45 | Eyepoint Inc. | EYPT | Apr 2024 | 15,325 | $207K | 1.16% | EC |
| 46 | Tarsus Pharmaceuticals Inc | TARS | Apr 2024 | 3,152 | $203K | 1.13% | EC |
| 47 | Terns Pharmaceuticals Inc. | TERN | Jan 2026 | 5,744 | $199K | 1.11% | EC |
| 48 | Trevi Therapeutics Inc | TRVI | Jan 2026 | 18,082 | $189K | 1.06% | EC |
| 49 | Nuvation Bio Inc | NUVB | Jul 2024 | 32,683 | $171K | 0.95% | EC |
| 50 | Nektar Therapeutics | NKTR | Jan 2026 | 4,438 | $166K | 0.92% | EC |
| 51 | Wave Life Sciences Ltd. | WVE | Jul 2024 | 12,665 | $164K | 0.91% | EC |
| 52 | Zevra Therapeutics Inc | ZVRA | Jan 2026 | 17,447 | $157K | 0.88% | EC |
| 53 | Omeros Corp | OMER | Jan 2026 | 13,401 | $157K | 0.87% | EC |
| 54 | Ocular Therapeutix Inc | OCUL | Apr 2024 | 16,629 | $152K | 0.85% | EC |
| 55 | CorMedix Inc. | CRMD | Jan 2026 | 19,469 | $151K | 0.84% | EC |
| 56 | Lenz Therapeutics Inc | LENZ | Jan 2026 | 8,293 | $131K | 0.73% | EC |
| 57 | Corcept Therapeutics Inc. | CORT | Apr 2024 | 3,003 | $120K | 0.67% | EC |
| 58 | Theravance Biopharma Inc | TBPH | Jan 2026 | 6,254 | $118K | 0.66% | EC |
| 59 | Alumis Inc | ALMS | Jan 2026 | 4,513 | $111K | 0.62% | EC |
| 60 | Septerna Inc. | SEPN | Jan 2026 | 4,623 | $108K | 0.60% | EC |
| 61 | Evolus Inc | EOLS | Apr 2024 | 19,927 | $93K | 0.52% | EC |
| 62 | Aquestive Therapeutics Inc | AQST | Jan 2026 | 27,867 | $82K | 0.46% | EC |
| 63 | N/A | N/A | Apr 2024 | 1 | $-35010 | -0.20% | DE |
| 64 | N/A | N/A | Apr 2024 | 1 | $-325689 | -1.82% | DE |
| 65 | N/A | N/A | Apr 2024 | 1 | $-391557 | -2.18% | DE |